A detailed history of Gilbert & Cook, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Gilbert & Cook, Inc. holds 6,142 shares of ABT stock, worth $689,808. This represents 0.1% of its overall portfolio holdings.

Number of Shares
6,142
Previous 6,135 0.11%
Holding current value
$689,808
Previous $637,000 9.89%
% of portfolio
0.1%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$100.07 - $118.13 $700 - $826
7 Added 0.11%
6,142 $700,000
Q2 2024

Aug 01, 2024

SELL
$100.73 - $112.44 $54,293 - $60,605
-539 Reduced 8.08%
6,135 $637,000
Q1 2024

May 02, 2024

SELL
$109.52 - $120.96 $96,596 - $106,686
-882 Reduced 11.67%
6,674 $758,000
Q4 2023

Feb 05, 2024

BUY
$90.19 - $110.4 $101,012 - $123,648
1,120 Added 17.4%
7,556 $831,000
Q3 2023

Nov 02, 2023

SELL
$95.53 - $114.62 $100,306 - $120,351
-1,050 Reduced 14.03%
6,436 $623,000
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $40,815 - $45,477
-405 Reduced 5.13%
7,486 $816,000
Q1 2023

May 05, 2023

BUY
$96.86 - $114.01 $228,008 - $268,379
2,354 Added 42.51%
7,891 $799,000
Q4 2022

Feb 09, 2023

SELL
$95.06 - $111.52 $13,118 - $15,389
-138 Reduced 2.43%
5,537 $608,000
Q3 2022

Nov 03, 2022

BUY
$96.76 - $112.03 $295,988 - $342,699
3,059 Added 116.93%
5,675 $556,000
Q2 2022

Aug 05, 2022

BUY
$102.07 - $123.37 $22,047 - $26,647
216 Added 9.0%
2,616 $284,000
Q1 2022

May 02, 2022

BUY
$114.02 - $139.04 $8,209 - $10,010
72 Added 3.09%
2,400 $284,000
Q4 2021

Jan 19, 2022

BUY
$115.53 - $141.46 $268,953 - $329,318
2,328 New
2,328 $328,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gilbert & Cook, Inc. Portfolio

Follow Gilbert & Cook, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilbert & Cook, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gilbert & Cook, Inc. with notifications on news.